A new study suggests that sponsors downplay their influence when reporting trials carried out in collaboration with academic researchers.

José Baselga of Memorial Sloan Kettering took millions of dollars from drug and health care companies but did not report the payments in his research articles.

The company’s announcement comes weeks after enrollment was suspended.

The EPA administrator had a sweet rental deal from a DC lobbyist, took pricey flights, and engineered whopping pay raises for aides.

An email exchange and an unusual meeting suggest a connection between an institute’s pursuit of industry support and the rejection of a grant application.

The editorial board at the International Journal of Occupational and Environmental Health accuses its publisher of promoting corporate interests.

The authors of two new studies on the payments suggest stricter guidelines are needed.

The proposed changes follow revelations in recent years that committee members preparing reports for the Academies did not disclose industry relationships. 

Expressions of concern will also be linked in study summaries.